Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 809

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 809
---
, exporting, having exported, distributing, having distributed, providing customer service and support, conducting medical affairs, conducting post-marketing safety surveillance and reporting of or otherwise
commercializing Licensed ADCs and/or Licensed Products. “Commercialize” and “Commercializing” have the correlative meanings.

1.13 “Commercially Reasonable Efforts” means, with respect to the efforts to be expended by a Party in
connection with a particular activity or objective to be conducted under this Agreement, [***]. Commercially Reasonable Efforts shall be determined on a Region-by-Region basis and it is anticipated that the level of effort and resources that
constitute “Commercially Reasonable Efforts” with respect to a particular Region will change over time.

1.14 “Competing Product” means (i) an ADC that includes [***] or (ii) an ADC that includes a [***].

1.15 “Control” (including any variations such as “Controlled” and
“Controlling”), in the context of intellectual property rights, material, data and/or other information or subject matter, means the possession by a Person of the ability (whether by ownership or license, other than pursuant to a
license granted to such Person by a Party to this Agreement) to grant the applicable access to, or a license or sublicense under this Agreement, without violating the terms of any agreement or other arrangement with any Third Party.

1.16 “Cover” means, with respect to a product, technology, process or method, that in the absence of ownership
of or a license granted under a Valid Claim, the manufacture, use, offer for sale, sale or importation of such product or the practice of such technology, process or method would infringe such Valid Claim. “Covering” and
“Covered by” have the correlative meanings.

G-3

1.17 “CPT113” means the linker-payload with [***].

1.18 “Data” means any and all manufacturing data, research data, pharmacology data, preclinical data, clinical
data and/or all Regulatory Filings and/or other regulatory documentation, information and submissions pertaining to, or made in association with an IND, Marketing Approval Application, or Regulatory Approval, for a Licensed ADC or Licensed Product,
in each case to the extent Controlled by WuXi Biologics as of the Effective Date or during the Term.

1.19 “Development” or “Develop” means
(a) non-clinical and clinical research and drug